Wealthcare Advisory Partners LLC Purchases 23 Shares of Intuitive Surgical, Inc. $ISRG

Wealthcare Advisory Partners LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,083 shares of the medical equipment provider’s stock after purchasing an additional 23 shares during the period. Wealthcare Advisory Partners LLC’s holdings in Intuitive Surgical were worth $2,762,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Brighton Jones LLC boosted its stake in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after acquiring an additional 731 shares in the last quarter. NBC Securities Inc. purchased a new position in shares of Intuitive Surgical during the first quarter valued at approximately $135,000. Clean Yield Group boosted its position in shares of Intuitive Surgical by 50.0% in the 1st quarter. Clean Yield Group now owns 81 shares of the medical equipment provider’s stock worth $40,000 after purchasing an additional 27 shares in the last quarter. Miracle Mile Advisors LLC grew its stake in shares of Intuitive Surgical by 1.8% in the 1st quarter. Miracle Mile Advisors LLC now owns 1,983 shares of the medical equipment provider’s stock worth $982,000 after buying an additional 35 shares during the last quarter. Finally, OLD National Bancorp IN grew its stake in shares of Intuitive Surgical by 19.0% in the 1st quarter. OLD National Bancorp IN now owns 5,295 shares of the medical equipment provider’s stock worth $2,622,000 after buying an additional 845 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Amy L. Ladd sold 336 shares of the company’s stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the sale, the director directly owned 1,074 shares of the company’s stock, valued at $504,898.14. The trade was a 23.83% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 45,224 shares of company stock valued at $21,716,492. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Down 0.6%

Shares of ISRG stock opened at $449.69 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The stock has a market capitalization of $161.20 billion, a P/E ratio of 62.72, a P/E/G ratio of 4.74 and a beta of 1.61. The firm’s 50 day moving average is $462.67 and its 200 day moving average is $499.82.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company’s revenue was up 21.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.78 EPS. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on ISRG shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Saturday, September 27th. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 23rd. UBS Group raised their price objective on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research note on Wednesday, July 23rd. Finally, Evercore ISI upped their target price on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 8th. Fourteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $594.19.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.